ERBB2 and breast carcinoma: The tumors developed in FVBhuHER2 mice recapitulated HER2 inter-tumor heterogeneity, as found in clinic and other preclinical models, such as HER2-positive breast cancer cell lines of human origin [42, 43] and breast cancer PDX collections [44, 45].